Coming Down Hard

McCoy goes after the C. E. O. of a pharmaceutical company who knowingly commissioned further clinical trials on a drug to extend its patent protection yielding millions of dollars of profit without disclosing that previous clinical studies had demonstrated that the drug created a high risk of suicide in its users.